GlaxoSmithKline PLC ADR (GSK) — Capital Reinvestment Ratio
Latest as of March 2026:
0.39x
GlaxoSmithKline PLC ADR (GSK) has a Capital Reinvestment Ratio of 0.39x as of March 2026, meaning it reinvests 0% of its operating cash flow ($1.14 Billion) in capital expenditures ($443.00 Million). See GlaxoSmithKline PLC ADR free cash flow generation to measure how efficiently the company converts operating cash flow to free cash.
Capital Reinvestment Ratio
0.39x
Capex / Operating Cash Flow
Operating Cash Flow
$1.14 Billion
USD
Capital Expenditures
$443.00 Million
USD
Data as of
Mar 2026
Most recent filing
GlaxoSmithKline PLC ADR Capital Reinvestment Ratio (1990–2025)
This chart tracks GlaxoSmithKline PLC ADR's Capital Reinvestment Ratio across 36 annual periods.
Annual Capital Reinvestment Ratio for GlaxoSmithKline PLC ADR (1990–2025)
Year-by-year Capital Reinvestment Ratio for GlaxoSmithKline PLC ADR from 1990 to 2025. For live market cap and broader valuation context, see market value of GlaxoSmithKline PLC ADR.
| Year | Reinvestment Ratio | Operating CF (USD) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2025 | 0.18x | $7.14 Billion | $1.32 Billion | ▼ -59.4% |
| 2024 | 0.45x | $6.55 Billion | $2.98 Billion | ▲ +119.8% |
| 2023 | 0.21x | $7.89 Billion | $1.63 Billion | ▼ -32.1% |
| 2022 | 0.31x | $7.40 Billion | $2.26 Billion | ▼ -17.2% |
| 2021 | 0.37x | $7.95 Billion | $2.93 Billion | ▲ +39.0% |
| 2020 | 0.27x | $8.44 Billion | $2.24 Billion | ▼ -1.6% |
| 2019 | 0.27x | $8.02 Billion | $2.16 Billion | ▲ +26.5% |
| 2018 | 0.21x | $8.42 Billion | $1.80 Billion | ▼ -33.0% |
| 2017 | 0.32x | $6.92 Billion | $2.20 Billion | ▼ -12.1% |
| 2016 | 0.36x | $6.50 Billion | $2.35 Billion | ▼ -51.1% |
| 2015 | 0.74x | $2.57 Billion | $1.90 Billion | ▲ +118.7% |
| 2014 | 0.34x | $5.18 Billion | $1.75 Billion | ▲ +43.6% |
| 2013 | 0.24x | $7.22 Billion | $1.70 Billion | ▼ -32.2% |
| 2012 | 0.35x | $4.38 Billion | $1.52 Billion | ▲ +63.5% |
| 2011 | 0.21x | $6.25 Billion | $1.33 Billion | ▼ -11.7% |
| 2010 | 0.24x | $6.80 Billion | $1.64 Billion | ▲ +0.7% |
| 2009 | 0.24x | $7.84 Billion | $1.87 Billion | ▼ -15.6% |
| 2008 | 0.28x | $7.31 Billion | $2.07 Billion | ▼ -23.5% |
| 2007 | 0.37x | $5.79 Billion | $2.14 Billion | ▼ -7.9% |
| 2006 | 0.40x | $3.96 Billion | $1.59 Billion | ▲ +90.0% |
| 2005 | 0.21x | $5.59 Billion | $1.18 Billion | ▲ +295.2% |
| 2004 | 0.05x | $4.77 Billion | $255.00 Million | ▼ -75.6% |
| 2003 | 0.22x | $4.85 Billion | $1.06 Billion | ▼ -45.4% |
| 2002 | 0.40x | $3.06 Billion | $1.23 Billion | ▲ +65.4% |
| 2001 | 0.24x | $4.61 Billion | $1.12 Billion | ▼ -59.3% |
| 2000 | 0.60x | $1.85 Billion | $1.10 Billion | ▼ -49.1% |
| 1999 | 1.17x | $510.00 Million | $597.00 Million | ▲ +1.0% |
| 1998 | 1.16x | $410.00 Million | $475.00 Million | ▲ +71.7% |
| 1997 | 0.67x | $615.00 Million | $415.00 Million | ▲ +42.9% |
| 1996 | 0.47x | $849.00 Million | $401.00 Million | ▼ -13.5% |
| 1995 | 0.55x | $1.25 Billion | $684.00 Million | ▲ +175.5% |
| 1994 | 0.20x | $2.45 Billion | $485.59 Million | ▼ -63.7% |
| 1993 | 0.55x | $1.05 Billion | $575.00 Million | ▼ -16.7% |
| 1992 | 0.66x | $927.00 Million | $608.00 Million | ▼ -27.5% |
| 1991 | 0.90x | $657.00 Million | $594.00 Million | ▼ -8.2% |
| 1990 | 0.99x | $615.00 Million | $606.00 Million | — |
Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow